
India's TB fight now has an X factor: AI-powered portable kit for early, fast detection
In that short span of time, the images of the chest X-ray had shown up on the laptop at the TB screening desk where an AI tool, fed with chest scan data of TB patients, had found no white patches in his lungs.
This hand-held, AI-enabled X-ray machine has been recently added as a screening tool in the national TB programme. Such quick screening helps identify undiagnosed TB cases within the patient's family, enabling early treatment and preventing further transmission within the household and community, particularly in remote areas.
How TB screening goes the last mile
At present, there are 473 such hand-held devices in use across the country. The government is in the process of procuring another 1,500 to diagnose missing TB cases. It is being used for screening vulnerable individuals — such as family members of TB patients, those with respiratory symptoms and those living with diabetes among others. It is also used for finding active cases in places where camps are conducted to test the already mapped vulnerable population in a district.
'Anyone who is found to be positive on the X-ray is asked to submit a sputum sample. They are given the sample container, asked to step out in the open area, and cough up sputum for testing. The sample is then sent to a government laboratory for testing,' said Dr Pamagal Kavithai, medical officer in-charge of the health centre.
A mobile device helps in remote pockets
While the devices work on the same principle as the stationary X-ray machines found in hospitals, they are highly portable and battery-operated, making them ideal for use in hard-to-reach areas with limited resources. The devices are extremely light — weighing between 1.8 kg and 2.8kg — and can be carried around in a backpack.
The device comes as a set of a digital SLR like X-ray beam generator, a flat digital panel X-ray detector, tripod to mount the detector and a laptop with in-built AI for reading the X-rays. The kits also contain a lead apron for technicians. The devices can take around 100 X-rays with a single charge — useful for camps in remote areas.
What are ICMR-validated devices?
There are three such AI-enabled X-ray devices that have been validated by the Indian Council of Medical Research (ICMR) — LabIndia's Mine2, Mylab's MyBeam, and Prognosys' Prorad Atlas. In fact, Prognosys is a sister company to Molbio, which is behind the cost-effective, portable, battery-operated molecular diagnostic machine called TrueNat that is being extensively used in the country's TB programme. The validations have shown that these devices produce X-rays comparable in quality to the ones produced by digital X-ray devices found in hospitals.
What about costs?
'Over the years, the sensitivity of the X-ray detectors has improved, so has the collimation — meaning there is minimal scattering and leakage from the X-ray beam in the generator. Very little radiation is now needed to get good quality scans. This is the reason now we can have hand-held devices that do not require much infrastructure,' said Santosh Kumar, business head, LabIndia, which used to import the devices from a South Korean company and has now started manufacturing it in India through licensing.
'Currently, there are around eight to 10 companies in India that have started building such machines. Mylab was one of the first. This boom has happened over the last two years. Earlier, such devices would have to be imported from other countries and would cost Rs 40-45 lakh, with an additional Rs 5 lakh to Rs 7 lakh a year for the AI. Now, the costs have reduced to a third,' said Hasmukh Rawal, managing director of Mylab, which also makes RT-PCR kits for TB diagnosis.
'It is an ultraportable, battery-operated X-ray machine. It can charge on any wall socket for four to six hours. With that charge you can do over a 100 X-rays over 8-10 hours, which is pretty much the entire day. The need for an X-ray room and the constraint of bringing people to a hospital or clinic set-up is completely removed. You can get diagnostic quality X-rays within a few seconds,' said Dr Krishna Prasad, head of Prognosys.
'Chest X-rays are good for screening of TB cases early on before people start showing symptoms. If these cases are detected in the community — especially as they are unlikely to come to a health centre for testing otherwise — we can prevent further spread of the infection and eliminate the disease,' said Kumar.
'The government has also developed an AI tool which can be utilised by Indian companies. We work with a few AI providers, including an AI based on the ICMR database of X-rays,' said Rawal.
ICMR's open dataset
The ICMR consortium working on developing and validating these innovations for TB has also created an open dataset of chest X-rays that can be used by companies for developing such AI tools. Over the last few years, ICMR's National Institute of Research in Tuberculosis has been building a database for such AI applications.
With an archive of thousands of X-rays, scientists from the institute started training an AI model to first recognise abnormalities on an X-ray, then to distinguish between different types of abnormalities such as fluid in chest or cancerous tumours, and finally to definitively identify whether a person has TB.
These portable X-ray machines were introduced in the national programme during the 100-day campaign that started in December last year, where vulnerable people from 347 high-risk districts were tested to find TB cases in the community, especially those without any symptoms and who were unlikely to reach a health centre for TB testing otherwise.
How screening helped in drawing an accurate TB map
During the 100-day campaign, 12.97 crore people were screened, of whom 7.19 lakh people were found to have TB. Importantly, 2.85 lakh of these patients were asymptomatic.
There is usually a gap between the number of estimated TB cases in a country and the actual number of cases diagnosed — the difference is considered to be the missing cases, who may continue to spread the infection in the country. In India, this gap has been reducing, with more and more people getting diagnosed and receiving treatment.
There were an estimated 28 lakh TB cases in India in 2023, with 25.2 lakh actually getting diagnosed, according to the latest available Global TB Report. To compare, there were an estimated 28.2 lakh TB cases in 2022 and 24.2 lakh were diagnosed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
4 hours ago
- Time of India
PAU defends GM maize trials, says its only for research
Ludhiana: In the wake of opposition from NGOs over field trials of genetically modified (GM) maize in Punjab at Punjab Agricultural University (PAU), the varsity defended its decision to proceed with research trials. The university clarified that it was not releasing GM maize for commercial use but only conducting scientific research, as per its institutional mandate and SOPs outlined by the department of biotechnology. The GM maize in question has been developed by agri-science company, Bayer. The crop has been genetically engineered with both herbicide-tolerant (HT) and insect-resistant Bacillus thuringiensis (BT) traits. Bayer applied to the Government of India's department of biotechnology for permission to conduct bio-safety trials under the statutory review committee on genetic manipulation (RCGM). The trials are being conducted in accordance with biosafety research level I (BRL-I) which are preliminary and advanced level II (BRL-II) norms. Environmentalists, along with a coalition of GM Free India, have raised serious objections to the Punjab government issuing the NoC for genetically modified maize trials. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Is it legal? How to get Internet without paying a subscription? Techno Mag Learn More Undo The coalition has written to the Punjab agriculture minister, urging him to immediately institute an inquiry into the scientific basis on which such an NoC was issued and sought its withdrawal. Trying to quell criticism, PAU vice-chancellor Dr Satbir Singh Gosal clarified that the university was not releasing GM maize for cultivation and had no role in its commercialisation. "We are not releasing this crop. That is the job of the government. PAU is only carrying out scientific research. Our mandate is to test and evaluate new technologies in agriculture so that policy makers, farmers, and society can make informed decisions based on science, not speculation," he said. NGOs against GM-free crops have expressed apprehensions of potential long-term ecological and health consequences of the adoption of GM crops. They have demanded a halt to all trials after Punjab government issued NoC for trials last month. However, PAU asserted that such assessments could not be made without data. "We cannot say whether any new crop, GM or not, is good or bad unless we research it," Dr Gosal said. "These are controlled, limited research trials under strict regulatory frameworks of the department of biotechnology," he added. Before the trials began, the project was reviewed and cleared by a Punjab-level committee consisting of officials from the Punjab department of agriculture, Punjab State Council for Science & Technology, biotechnology incubator, state health department and PAU scientists. The committee examined all safety protocols and agreed that the trials could be conducted under strict monitoring adhering to the norms. PAU officials stressed that the university has a long record of research on transgenic crops and has been evaluating GM crops, including BT cotton. Officials also pointed to the university's rejection of nano urea, a product that was widely promoted by all sections, including the central government. "We tested nano urea in our research fields and found it ineffective in Punjab's soil and crop conditions. We did not recommend it. Now, even the central government is rethinking it. That shows the importance of independent, university-led research," the vice-chancellor said. More than 30 countries, including the United States and Canada are growing GM crops. In India, BT cotton, despite initial opposition and widespread myths, has now been widely adopted and accounts for majority of cotton cultivation. "There were stories that animals died after eating BT cotton leaves. But none of those were proven scientifically. Today, BT cotton is key crop in agriculture," Dr Gosal said, adding, "We are trying to avoid repeating the same cycle of myth-based panic. We must let data speak. A growing number of farmers in Punjab have been informally demanding more advanced BT varieties such as BT 3 and BT 4, citing growing resistance to older versions. "If farmers are demanding solutions, we must investigate them scientifically first," he said.


Time of India
5 hours ago
- Time of India
TB screening finds 37 cases in urban slums
N ew Delhi: Delhi health department's ongoing community-based tuberculosis (TB) screening drive in urban slums has identified 37 cases from among 9,200 people screened so far. The initiative, which uses artificial intelligence (AI)-powered diagnostics, aims to facilitate early detection, interrupt transmission chains, and swiftly reduce TB prevalence in high-risk areas. The first phase of the programme targets six high-burden National TB Elimination Program (NTEP) districts — Nehru Nagar, Narela, Karawal Nagar, Moti Nagar, BJRM and Shastri Park. You Can Also Check: Delhi AQI | Weather in Delhi | Bank Holidays in Delhi | Public Holidays in Delhi The department has deployed 21 portable AI-powered X-ray units, supported by 21 radiographers, 21 field officers and 7 laboratory technicians. According to the India TB Prevalence Survey (2019–2021), Delhi has the highest TB burden in the country, with a prevalence of 747 cases per lakh of the population and an infection rate of 61% (range: 57–65%). The capital has launched an intensive, slum-focused TB screening campaign designed to identify undiagnosed cases and rapidly reduce community transmission. Officials said the campaign aims to screen 40 lakh people over three years, with a goal of reducing TB prevalence by 25% in the targeted districts. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like An engineer reveals: One simple trick to get internet without a subscription Techno Mag Learn More Undo Camps have been set up in both public and private spaces to demonstrate handheld X-ray technologies. A hub-and-spoke model has been implemented to ensure timely sputum collection and transportation, with a focus on TB-HIV co-infection for integrated care. Support from the Indian Council of Medical Research (ICMR) strengthened the effort, with the provision of 10 PathoDetect molecular testing machines, 7 additional handheld X-ray units, and ongoing technical guidance, said officials. A comprehensive advocacy, social mobilisation, and communication strategy is being rolled out to raise awareness, reduce stigma, and encourage active participation in slum clusters. The department has mapped over 600 slum localities across Delhi for coverage. The screening is prioritising high-risk groups such as people with diabetes, hypertension, compromised immunity, TB patient contacts, migrant labourers, the homeless, residents of JJ clusters and unauthorised colonies, and others living in densely populated areas.


Time of India
13 hours ago
- Time of India
What 1 Gulab Jamun is hiding could change the way India eats
A crispy samosa. A fizzy drink. A chocolate pastry after lunch. These may seem like harmless to consume, even occasionally. But what if these items come tagged with hidden risks, risks that could quietly damage health, day by day? The Indian government has launched a bold step inspired by the Prime Minister's 'Fit India' mission, which is to introduce Sugar and Oil Boards across public spaces. These visual tools aren't just posters, they're messengers, bringing attention to the sugars and fats that sneak into daily meals. With rising obesity, heart disease, and diabetes numbers, it's time to stop and look. What seems like comfort food may actually be fueling a national health crisis. The reality behind the posters: What sugar and oil boards actually say The new Sugar and Oil Boards don't rely on generic warnings. They lay out specific, relatable, and shocking facts. For example, that soft drink on the desk? It might carry 7 to 8 teaspoons of sugar. The innocent-looking banana chips could be swimming in oil. These boards recommend: Fat intake: 27–30 grams/day Sugar intake: Not more than 25g/day for adults, 20g/day for children These are not just random numbers, they're based on scientific findings from the Indian Council of Medical Research-National Institute of Nutrition (ICMR-NIN) . Why these boards matter more than we think There's a quiet war being fought against lifestyle diseases. Obesity, once dismissed as a personal issue, now has national consequences. According to The Lancet , India could see 44.9 crore obese or overweight people by 2050. These aren't just numbers. They translate into: Spiking diabetes cases Heart conditions at younger ages Early onset of hypertension Reduced productivity Rising healthcare costs The new boards, therefore, serve a powerful purpose: they act as behavioural nudges, guiding food choices without bans or enforcement. Just like anti-smoking labels changed public perception, these boards may redefine food culture. The sugar trap: More than just a sweet tooth Sweet isn't always harmless. Excessive sugar has been linked with: Type 2 diabetes Fatty liver disease Increased belly fat Mood fluctuations Even cognitive decline But here's the catch: most of the sugar consumed is hidden. It's in ketchup, fruit juices, breakfast cereals, and so-called healthy granola bars. By displaying sugar content in everyday foods, these boards peel off the marketing layer and reveal the bitter truth beneath the sweet. The oil overload From street-side pakoras to fancy burgers, oil makes food taste good, but in excess, it weighs down health. The danger isn't just in how much is added, but what kind is used. Hydrogenated oils and trans fats are commonly found in: Bakery items Fried snacks Instant foods They contribute to: Artery clogging High cholesterol Weight gain Chronic fatigue Dr Sunil Gupta told TOI, 'Sugar and trans fats are the new tobacco.' The comparison may sound dramatic, but the consequences aren't. Small moves with big impact Some ministries have already adopted the message. Healthy replacements like: Sattu drinks Millet snacks Green tea Coconut water are replacing sugary teas and fried bites in canteens.